Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04416269 · ClinicalTrials.gov registry record · Phase 4
Oral Anti Diabetic Agents in the Hospital
A Phase 4 study of Diabetes Mellitus, sponsored by Emory University.
- Active
- Registry status
- Phase 4
- Development phase
- 255
- Enrollment target
- 3
- Study locations
NCT04416269: Active Phase 4 study of Diabetes Mellitus, sponsored by Emory University.
NCT04416269 is a Phase 4 study of Diabetes Mellitus that is active but no longer recruiting, run by Emory University. The registered enrollment target is 255 participants, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (86% lower). The trial reports 3 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04416269, a Phase 4 study of Diabetes Mellitus, is active but no longer recruiting, sponsored by Emory University.
- ACTIVE NOT RECRUITING
- Registry status
- Phase 4
- Development phase
- 255 participants
- Enrollment target
- 3
- Study locations
Study Summary
This randomized controlled clinical trial will assess whether continuation of home oral antidiabetic agents during hospitalization can be used as a safe and effective alternative to insulin therapy in the management of diabetes in the hospital. The primary outcome of the study is to determine differences in glycemic control as measured by mean daily blood glucose concentration between oral antidiabetic medications and basal bolus therapy in hospitalized patients with type 2 diabetes (T2D).
Primary Outcome
Mean daily BG concentration is compared between OADs and basal bolus therapy in hospitalized patients with type 2 diabetes (T2D).
Conditions Studied
Interventions
- DRUG Oral Anti-diabetes Drugs alone
- DRUG Basal bolus insulin
- DRUG Supplemental insulin
- DEVICE Continuous glucose monitoring (CGM)
Study Locations (3)
Georgia
- Emory University Hospital Midtown - Atlanta
- Emory University Hospital - Atlanta
- Grady Memorial Hospital - Atlanta
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2020-08-07 |
| Est. Completion | 2026-03 |
| Phase | Phase 4 |
What the registry record for NCT04416269 still lists
NCT04416269 is an interventional study that assigns participants to a tested intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, below the 1,866-participant average among 208 other Diabetes Mellitus trials with a reported enrollment target (86% lower).
The record links to 1 condition, with Diabetes Mellitus appearing as the primary indexed condition, and to 4 interventions - of which Oral Anti-diabetes Drugs alone is the first listed.
NCT04416269 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04416269 about?
NCT04416269 is a clinical study titled "Oral Anti Diabetic Agents in the Hospital". This randomized controlled clinical trial will assess whether continuation of home oral antidiabetic agents during hospitalization can be used as a safe and effective alternative to insulin therapy in the management of diabetes in the hospital. The primary outcome of the study is to determine differ...
What is the current status of trial NCT04416269?
This trial is currently active not recruiting. It is a Phase 4 study. The enrollment target is 255 participants. The study started on 2020-08-07. Estimated completion is 2026-03.
What conditions does trial NCT04416269 study?
This clinical trial studies the following conditions: Diabetes Mellitus.
What interventions are being tested in trial NCT04416269?
The interventions under investigation include: Oral Anti-diabetes Drugs alone (DRUG), Basal bolus insulin (DRUG), Supplemental insulin (DRUG), Continuous glucose monitoring (CGM) (DEVICE).
Who is sponsoring clinical trial NCT04416269?
This trial is sponsored by Emory University, which has 1,208 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04416269 being conducted?
This trial has 3 study locations across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetes Mellitus
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04416269's enrollment target sits among peer trials
255 76th of 208 higher than 133 of 208 other Diabetes Mellitus trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Diabetes Mellitus trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Impact GLP-1 Agonists Following Bariatric
RECRUITING · Phase 4
-
People With CHC Who Achieved a Sustained Virological Response Following Therapy With Direct Acting Antiviral Agents
ACTIVE NOT RECRUITING · Phase 4
-
The Management of Glucocorticoid-Induced Hyperglycemia in Hospitalized Patients
COMPLETED · Phase 4
-
Impact of Empagliflozin on Functional Capacity in Heart Failure with Preserved Ejection Fraction
COMPLETED · Phase 4
-
Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone.
COMPLETED · Phase 4
-
A Study of Rapid-Acting Mealtime Insulin in Children and Adolescents With Newly Diagnosed Type 1 Diabetes Mellitus
COMPLETED · Phase 4
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI